REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. is based in Ecuador. The head office is in Quito. It operates in the General Medical and Surgical Hospitals industry. The company was established on May 31, 2022. It currently has a total number of 2 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 53029.39% in 2024. Over the same period, its total assets grew by 660.68%.

Headquarters
Calle Miguel Medina, Lote 5
Quito; Pichincha;

Contact Details: Purchase the Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. report to view the information.
Registered Capital:
Purchase the Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. report to view the information.
Financial Auditors:
Purchase the Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. report to view the information.
Incorporation Date:
May 31, 2022
Key Executives
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Instituto Intercientifico America Genomica Humana Iabyageh S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
53029.39%
Total operating revenue
53029.39%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
660.68%
Total equity
485.12%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?